Vanguard Capital Management
TNYA icon

Vanguard Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Vanguard Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.25M Sell
7,101,263
-1,381,025
-16% -$1.05M ﹤0.01% 3097
2026
Q1 		$5.87M Buy
+8,482,288
New +$6.26M ﹤0.01% 2992

Other funds holding TNYA

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management's TNYA Position: Q2 2026 in Review

Vanguard Capital Management reduced its Tenaya Therapeutics (TNYA) stake by 16% in Q2 2026, selling an estimated $1.05M and leaving 7,101,263 shares worth $5.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

Vanguard Capital Management first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.87M in Q1 2026. 98 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Vanguard Capital Management held 7,101,263 shares of Tenaya Therapeutics worth $5.25M as of Q2 2026.
  • Vanguard Capital Management sold 1,381,025 Tenaya Therapeutics shares in Q2 2026, an estimated $1.05M.
  • Tenaya Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3097 holding.
  • Vanguard Capital Management first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Tenaya Therapeutics position peaked at $5.87M in Q1 2026.
  • 98 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.